[The effects of beta-adrenergic blocking agents on the electrocardiogram of normal subjects]. 1966

E Bacuzzi, and F Barbaresi, and R Starcich

UI MeSH Term Description Entries
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents

Related Publications

E Bacuzzi, and F Barbaresi, and R Starcich
December 1967, Bollettino della Societa italiana di biologia sperimentale,
E Bacuzzi, and F Barbaresi, and R Starcich
February 1967, Annals of the New York Academy of Sciences,
E Bacuzzi, and F Barbaresi, and R Starcich
November 1967, Schweizerische medizinische Wochenschrift,
E Bacuzzi, and F Barbaresi, and R Starcich
January 1982, Journal of emergency nursing,
E Bacuzzi, and F Barbaresi, and R Starcich
September 1982, Midwife, health visitor & community nurse,
E Bacuzzi, and F Barbaresi, and R Starcich
March 1967, The New England journal of medicine,
E Bacuzzi, and F Barbaresi, and R Starcich
January 1967, Duodecim; laaketieteellinen aikakauskirja,
E Bacuzzi, and F Barbaresi, and R Starcich
May 1969, Il Policlinico. Sezione pratica,
E Bacuzzi, and F Barbaresi, and R Starcich
January 1971, Journal of postgraduate medicine,
Copied contents to your clipboard!